LERCANIDIPINE vs LETERMOVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LERCANIDIPINE vs LETERMOVIR: Safety Overview
| Metric | LERCANIDIPINE | LETERMOVIR |
|---|---|---|
| Total FAERS Reports | 3,767 | 1,416 |
| Deaths Reported | 248 | 252 |
| Death Rate | 6.6% | 17.8% |
| Hospitalizations | 2,249 | 398 |
| Average Patient Age | 65.8 yrs | 46.6 yrs |
| % Female Patients | 47.8% | 42.7% |
| FDA Approval Date | N/A | Aug 30, 2024 |
| Manufacturer | N/A | Merck Sharp & Dohme LLC |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |